Related Experiment Video
Updated: Aug 8, 2026

Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research
Published on: April 19, 2017
[Activated C protein resistance manifested by cutaneous necrosis after interferon alpha injection: case report]
F Plurien1, Z Le Lostec, C Pauwels
1Service de médecine interne A, centre hospitalier Poissy-Saint-Germain, Saint-Germain-en-Laye, France.
Insights
Alpha interferon treatment can rarely cause skin necrosis. This case links interferon-induced skin necrosis to a patient with resistance to activated protein C, suggesting coagulation issues may be involved.
Area of Science:
- Dermatology
- Hematology
- Pharmacology
Background:
- Cutaneous necrosis is an uncommon side effect of alpha interferon therapy.
- The exact mechanism behind interferon-induced skin necrosis is not fully understood.
- A local thrombotic action of interferon has been hypothesized.
Observation:
- A 64-year-old male with HIV-related Kaposi's sarcoma developed skin necrosis.
- The patient had been treated with interferon alpha for nine months.
- The patient exhibited known resistance to activated protein C.
Findings:
- This is the first reported case associating interferon-induced cutaneous necrosis with activated protein C resistance.
- The patient's presentation suggests a potential link between coagulation abnormalities and this adverse drug reaction.
Implications:
- Investigating coagulation disorders is recommended for patients experiencing interferon treatment-induced cutaneous necrosis.
- This case raises questions about a potential pro-coagulant profile that may predispose individuals to this side effect.
- Further research is needed to elucidate the role of coagulation in interferon-induced skin necrosis.
Introduction:
Cutaneous necrosis occurring in the course of treatment by alpha interferon is an uncommon side-effect. Its physiopathologic mechanism remains obscure. A local thrombotic action of interferon has been suggested to explain its occurrence.
Exegesis:
A 64-year-old male patient with human immunodeficiency virus-related cutaneous Kaposi's sarcoma presented cutaneous necrosis after a 9-month treatment by interferon alpha, while his resistance to activated protein C had already been demonstrated. To our knowledge, this is the first case ever described regarding the association of interferon-induced cutaneous necrosis with activated protein C resistance.
Conclusion:
This suggests that in case of interferon treatment-induced cutaneous necrosis coagulation disorders should be investigated and questions the existence of a particular "pro-coagulant profile" facilitating this side effect.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Inhibitors of Viral Protein Synthesis
